Ce3 is a full-service CRO specializing in early phase clinical development services for the biotech industry. Our therapeutic focus is in oncology, inclusive of cell and gene therapy. We understand the many needs and collaborative nature of biotech companies as we have been focused in this growing industry since our inception in 2005. Our people, processes, and technology platforms are developed to effortlessly manage scientifically and logistically complex clinical trials at a competitive price.
CellGenix is a premium supplier of high-quality reagents and tools for cell therapy applications. Our mission is to enable and accelerate safe and efficient transition of cell, gene and tissue engineered products from preclinical to post-approval clinical applications for the benefit of patients worldwide.
Charter Medical, Ltd. is a subsidiary of Fenner PLC. We have a 25 year history of developing and providing specialty single-use products to the blood transfusion, cell therapy, biotechnology and pharmaceutical markets. Charter Medical is committed to providing quality products and excellent service on-time every day. We will exceed customers’ expectations by integrating continuous improvements and ensuring compliance with regulatory requirements in everything we do.
Genscript is a leading biotech company providing life sciences services and products to scientists over 100 countries worldwide. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research, translational biomedical research, and early stage pharmaceutical development.
HemaCare is a leading blood products and services company serving the scientific community. HemaCare provides healthy and disease state human primary blood cells derived from normal and mobilized peripheral blood, bone marrow and cord blood for advanced biomedical research. HemaCare also supports cell therapy research, clinical trials and commercialization with customized apheresis collections, and provides a wide range of consulting services in SOP development, personnel training, quality and regulatory compliance. www.hemacare.com
Key Biologics provides biological products to the cell therapy industry worldwide. Non-mobilized and G-CSF mobilized MNC collections are performed under proprietary IRB-approved protocols. Three G-CSF schedules are available: 4day/10ug per kg/single collection, 5day/10ug per kg/single collection and 5day/5ug per kg/two collections. Key operates the Spectra, Optia and Amicus devices allowing customers to compare MNC product characteristics that could influence manufacturing of autologous or allogeneic cell-based therapies.
Randox Biosciences have been developing and manufacturing antibodies, proteins and conjugates for over 30 years for use in Randox Laboratories diagnostic kits, including our patented Biochip Array Technology kits. We offer an extensive portfolio of over 900 products for a multitude of R&D applications including more than 500 monoclonal and polyclonal antibodies and over 140 human recombinant proteins as well as antibody fragments. In addition we also offer a customisation service for all products… Read More
A critical factor facing the Cell Therapy industry is choosing technologies and partners that can deliver scale. There’s no other field of medicine that requires the level of mass customization of production and careful orchestration of production pathways that cell therapies demand. From sample collection through logistics, manufacturing and final transplantation, TrakCel’s proven technology integrates and orchestrates every aspect of your Autologous and Allogeneic supply chains in a scalable, compliant and validated technology platform.
Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Our out-of-the-box PAS-X software product is run by the majority of the world’s top 30 pharmaceutical and biotech companies but also by many mid-sized manufacturers. Werum IT solutions help pharma manufacturers to increase efficiency, improve productivity, and meet regulatory requirements. The range of projects includes global MES programs with multi-site rollouts all over the world as well as single-site solutions in individual countries.
BioNTech Innovative Manufacturing Services (IMFS) is a German CDMO specialized in the development and manufacturing of cell and gene therapy products (viral vectors, cells and ivt mRNA). From process development through commercial supply, we offer the expertise and services necessary to help our clients deliver their innovative CGT therapies. All services are fully integrated and supervised by our QA department, ensuring efficient and compliant manufacturing in our state-of-the-art GMP facility.